Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Henrik Petersen is active.

Publication


Featured researches published by Henrik Petersen.


Radiotherapy and Oncology | 2012

FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: Results from the DAHANCA 24 trial

Lise Saksø Mortensen; Jørgen Johansen; Jesper F. Kallehauge; Hanne Primdahl; Morten Busk; Pernille Lassen; Jan Alsner; Brita Singers Sørensen; Kasper Toustrup; Steen Jakobsen; Jørgen B. B. Petersen; Henrik Petersen; J. Theil; Marianne Nordsmark; Jens Overgaard

PURPOSE Hypoxia is a cause of resistance to radiotherapy, especially in patients with head and neck squamous cell carcinoma (HNSCC). The purpose of this study was to evaluate (18)F-fluoroazomycin arabinoside (FAZA) positron emission tomography (PET)/computed tomography (CT) hypoxia imaging as a prognostic factor in HNSCC patients receiving radiotherapy. MATERIAL AND METHODS Forty patients with HNSCC treated with radiotherapy (66-76 Gy) were included. Static FAZA PET/CT imaging 2h post injection was conducted prior to irradiation. The hypoxic volume (HV) was delineated using a tumor-to-muscle value ≥ 1.4. In 13 patients, a repetitive FAZA PET/CT scan was conducted during the radiotherapy treatment. RESULTS A hypoxic volume could be identified in 25 (63%) of the 40 tumors. FAZA PET HV varied considerably with a range from 0.0 to 30.9 (median: 0.3) cm(3). The T(max)/M(med) ranged from 1.1 to 2.9 (median: 1.5). The distribution of hypoxia among the Human Papillomavirus (HPV) positive (12/16) and negative (13/24) tumors was not significant different. In the FAZA PET/CT scans performed during radiotherapy, hypoxia could be detected in six of the 13 patients. For these six patients the location of HV remained stable in location during radiotherapy treatment, though the size of the HV decreased. In 30 patients a positive correlation was detected between maximum FAZA uptake in the primary tumor and the lymph node. During a median follow up of 19 months a significant difference in disease free survival rate with 93% for patients with non hypoxic tumors and 60% for patients with hypoxic tumors could be detected. CONCLUSION This study emphasizes the role of FAZA PET/CT imaging as a suitable assay with prognostic potential for detection of hypoxia in HNSCC.


BJUI | 2012

[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients

Mads Hvid Poulsen; Kirsten Bouchelouche; Poul Flemming Høilund-Carlsen; Henrik Petersen; Oke Gerke; Signe Inglev Steffansen; Niels Marcussen; Niels Svolgaard; Werner Vach; Ulla Geertsen; Steen Walter

Study Type – Diagnostic (exploratory cohort)


BJUI | 2014

Spine metastases in prostate cancer: comparison of technetium-99m-MDP whole-body bone scintigraphy, [18F]choline positron emission tomography(PET)/computed tomography (CT) and [18F]NaF PET/CT

Mads Hvid Poulsen; Henrik Petersen; Poul Flemming Høilund-Carlsen; Jørn Skibsted Jakobsen; Oke Gerke; Jens Karstoft; Signe Inglev Steffansen; Steen Walter

To compare the diagnostic accuracy of the following imaging techniques in the detection of spine metastases, using magnetic resonance imaging (MRI) as a reference: whole‐body bone scintigraphy (WBS) with technetium‐99m‐MDP, [18F]‐sodium fluoride (NaF) positron emission tomography (PET)/computed tomography (CT) and [18F]‐fluoromethylcholine (FCH) PET/CT.


BJUI | 2010

[18F]-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study

Mads Hvid Poulsen; Kirsten Bouchelouche; Oke Gerke; Henrik Petersen; Birgitte Svolgaard; Niels Marcussen; Niels Svolgaard; Mattias Ögren; Werner Vach; Poul Flemming Høilund-Carlsen; Ulla Geertsen; Steen Walter

Study Type – Diagnostic (case series)
Level of Evidence 4


European Journal of Preventive Cardiology | 2012

Discrepancy between coronary artery calcium score and HeartScore in middle-aged Danes: the DanRisk study

Axel Cosmus Pyndt Diederichsen; Niels Peter Sand; Bjarne Linde Nørgaard; Jess Lambrechtsen; Jesper M. Jensen; Henrik Munkholm; Ahmed Aziz; Oke Gerke; Kenneth Egstrup; Mogens Lytken Larsen; Henrik Petersen; Poul Flemming Høilund-Carlsen; Hans Mickley

Background: Coronary artery calcification (CAC) is an independent and incremental risk marker. This marker has previously not been compared to the HeartScore risk model. Design: A random sample of 1825 citizens (men and women, 50 or 60 years of age) was invited for screening. Methods: Using the HeartScore model, the 10-year risk of fatal cardiovascular events based on gender, age, smoking, systolic blood pressure, and total cholesterol was estimated. A low risk was defined as <5%. The CAC score was calculated from a non-contrast enhanced cardiac-CT scan and given in Agatston U. Results: A total of 1257 (69%) of the invited subjects were interested in the screening. Due to previous cardiovascular disease or diabetes mellitus, 101 were excluded. Of the remaining 1156, 47% were men and 53% women; one half were 50 years old and the other half 60 years old. A low HeartScore was found in 901 of which 334 (37%) had CAC. A high HeartScore was recorded in 251 of which 80 (32%) did not have any CAC. High HeartScores and CAC were significantly more common in males than females. Conclusions: CAC is common in healthy middle-aged Danes with a low HeartScore, and, on the contrary, high-risk subjects very frequently do not have CAC. The therapeutic and prognostic implications of these observations remain to be clarified.


European Journal of Cardio-Thoracic Surgery | 2009

The value of mediastinal staging with endobronchial ultrasound-guided transbronchial needle aspiration in patients with lung cancer

Henrik Petersen; Jens Eckardt; Ardeshir Hakami; Karen Ege Olsen; Ole Dan Jørgensen

OBJECTIVE To evaluate the diagnostic yield, the learning curve and the safety of endobronchial ultrasound-guided transbronchial needle biopsy (EBUS-TBNA) in mediastinal staging of patients with lung cancer. METHODS Mediastinal staging was performed with EBUS-TBNA according to the Danish national guidelines in patients fulfilling one or more of the following criteria: (1) central tumour; (2) enlarged (>10 mm) mediastinal lymph nodes on computed tomography; or (3) positron emission tomography (PET)-positive mediastinal lymph nodes. The study period began in January 2006 when EBUS-TBNA was introduced in the department and ended in December 2007. All records were reviewed retrospectively. None of the four examiners had any previous experience with EBUS-TBNA or ultrasound when the study began. All examinations were performed under general anaesthesia. Patients without useful cytological material from the EBUS-TBNA were subjected to a supplementary standard cervical mediastinoscopy if the mediastinal lymph nodes were found to be enlarged (>10 mm), PET positive or if the examiner was insecure of the result of the EBUS-TBNA. Patients with mediastinal lymph node involvement, detected by EBUS-TBNA or standard cervical mediastinoscopy, were referred to oncological treatment, while those without mediastinal lymph node involvement underwent--if they were otherwise eligible for surgery--resection and systematic lymph node sampling either by thoracotomy or by video-assisted thoracoscopy. Final mediastinal staging was defined as positive if mediastinal lymph node involvement was detected by EBUS-TBNA, standard cervical mediastinoscopy or surgery, or defined as negative otherwise. RESULTS A total of 157 patients were included in the study. N2/N3 disease was found in 67 patients (42.6%). EBUS-TBNA missed the mediastinal spread in 10 patients. Five of the ten patients had lymph node metastases in station 5, 6 or 8--out of reach of EBUS-TBNA or standard cervical mediastinoscopy. EBUS-TBNA had a sensitivity of 0.85 (0.74-0.93) and a negative predictive value of 0.90 (0.82-0.95). No complications occurred from EBUS-TBNA. The number of supplementary standard cervical mediastinoscopies decreased significantly in the study period. CONCLUSION The results of this study suggest that staging of the mediastinum with EBUS-TBNA is safe and easy to learn--even without previous experience with ultrasound. The diagnostic yield of EBUS-TBNA is in accordance with the yield of standard cervical mediastinoscopy reported in the literature. We do not find any indications in the present study of the recommended necessity for mediastinoscopy in all EBUS-TBNA-negative patients.


Scandinavian Cardiovascular Journal | 2009

Diagnostic value of cardiac 64-slice computed tomography: Importance of coronary calcium

Axel Cosmus Pyndt Diederichsen; Henrik Petersen; Lisette Okkels Jensen; Per Thayssen; Oke Gerke; Niels C.F. Sandgaard; Poul Flemming Høilund-Carlsen; Hans Mickley

Objectives. Coronary computed tomography angiography (CTA) has proven clinically useful for non-invasive assessment of coronary pathology. However, coronary calcium can reduce its diagnostic value. The objective of this study was to define a calcium score above which CTA appears less reliable. Design. We prospectively investigated 109 patients referred for elective coronary angiography (CA). With a 64-slice CT-scanner, coronary calcium was determined and expressed in Agatston unit (AU). A significant coronary stenosis was defined as ≥50% luminal diameter reduction. Following blinded interpretation, diagnostic values of CTA at different levels of AU were calculated using quantitative CA as reference. Results. A strong association with stent and the severity of coronary calcium was observed. In patients without stents (n = 91) sensitivity, specificity and positive and negative predictive value for presence of significant stenosis were: 100%, 91%, 74%, and 100% in patients with a calcium score ≤400 AU versus 100%, 17%, 75%, and 100% in patients with a score >400 AU. Conclusions. The diagnostic accuracy of CTA in patients with no or little coronary calcium is excellent. However, in patients with an Agatston score >400 specificity declines and therefore, these patients should not go on to CTA, but be referred to CA instead.


European Journal of Haematology | 2013

Extramedullary disease in patients with acute myeloid leukemia assessed by (18)F-FDG PET

Anne-Sofie Weindel Ibar Cribe; Maria Steenhof; Claus Werenberg Marcher; Henrik Petersen; Henrik Frederiksen; Lone S. Friis

Prevalence of extramedullary disease (EMD) in acute myeloid leukemia (AML) at the time of diagnosis is unknown. Previous estimates range from 2.5% to 30.5% and are usually based on clinical examination. This may cause an under diagnosis of EMD as not all extramedullary manifestations are easily detectable. Few recent studies have used positron emission tomography (PET) scans for diagnosing EMD in patients AML.


European Radiology | 2011

PET/CT without capacity limitations: a Danish experience from a European perspective

Poul Flemming Høilund-Carlsen; Oke Gerke; Mie Holm Vilstrup; Anne Lerberg Nielsen; Anders Thomassen; Søren Hess; Mette M. Høilund-Carlsen; Werner Vach; Henrik Petersen

ObjectivesWe report the 3-year clinical experience of a large new Danish PET/CT centre without capacity limitations in relation to national and European developments.MethodsThe use of PET/CT in cancer was registered from early 2006 to early 2009 to judge the impact on patient management and to compare it with national and European trends.Results6056 PET/CT examinations were performed in 4327 patients. Activity increased by 86 examinations per month compared with the same month the year before. Referrals came primarily from oncology (23.0%), haematology (21.6%), surgery (12.6%), internal medicine (12.7%) and gynaecology (5.5%). Referral indications were diagnosis (31.3%), staging (22.3%), recurrence detection (21.2%), response evaluation (17.0%) and other (8.2%). Response from nearly 60% of users showed that PET/CT caused a change in diagnosis and/or staging and/or treatment plan in 36.0% of cases. During the study period, there was a steep increase in the national use of FDG and in the European use of PET/CT.ConclusionsWe recorded a constantly increasing use of PET/CT that caused a change in diagnosis and/or staging and/or treatment plan in 36.0% of cases. In line with national and European trends this may suggest a shift in favour of functional rather than anatomical imaging.


Journal of Internal Medicine | 2012

The relation between coronary artery calcification in asymptomatic subjects and both traditional risk factors and living in the city centre: a DanRisk substudy

Jess Lambrechtsen; Oke Gerke; Kenneth Egstrup; Niels Peter Sand; Bjarne Linde Nørgaard; Henrik Petersen; Hans Mickley; Axel Cosmus Pyndt Diederichsen

Abstract.  Lambrechtsen J, Gerke O, Egstrup K, Sand NP, Nørgaard BL, Petersen H, Mickley H, Diederichsen ACP (Svendborg Hospital, Svendborg; Odense University Hospital, Odense; SVS, Esbjerg; Institute of Regional Health Services Research, University of Southern Denmark; Vejle Hospital, Vejle; and Odense University Hospital, Odense, Denmark). The relation between coronary artery calcification in asymptomatic subjects and both traditional risk factors and living in the city centre: a DanRisk substudy. J Intern Med 2012; 271: 444–450.

Collaboration


Dive into the Henrik Petersen's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Oke Gerke

Odense University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anders Thomassen

Odense University Hospital

View shared research outputs
Top Co-Authors

Avatar

Søren Hess

Odense University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hans Mickley

Odense University Hospital

View shared research outputs
Top Co-Authors

Avatar

Allan Johansen

Odense University Hospital

View shared research outputs
Top Co-Authors

Avatar

Mads Hvid Poulsen

Odense University Hospital

View shared research outputs
Top Co-Authors

Avatar

Poul-Erik Braad

Odense University Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge